Perrigo Company plc

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-04-12 pm EDT 5-day change 1st Jan Change
30.32 USD -3.07% Intraday chart for Perrigo Company plc -3.44% -5.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Piper Sandler Raises Perrigo's Price Target to $39 From $35, Maintains Overweight Rating MT
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors RE
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost MT
Multiple CVS Caremark Plans Reportedly to Cover Perrigo's Opill at No Cost MT
Sector Update: Health Care Stocks Rise Late Afternoon MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading MT
Perrigo Shares Rise After Wisconsin Governor Makes Birth Control Pill Free for Medicaid Members MT
Transcript : Perrigo Company plc Presents at UBS Global Consumer and Retail Conference 2024, Mar-13-2024 04:00 PM
Perrigo Company plc Announces Erica L. Mann Not to Stand for Re-Election to its Board of Directors CI
Perrigo Company plc Commences Shipments of Opill to Retailers Nationwide, Empowering Millions to Enter A New Era of Reproductive Health Access in the United States CI
Perrigo Co Insider Bought Shares Worth $252,168, According to a Recent SEC Filing MT
JPMorgan Cuts Price Target on Perrigo to $41 From $48, Maintains Overweight Rating MT
Perrigo Company plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sector Update: Health Care Stocks Mixed Premarket Tuesday MT
Sector Update: Health Care MT
Transcript : Perrigo Company plc, Q4 2023 Earnings Call, Feb 27, 2024
Perrigo Q4 Adjusted Earnings Increase, Net Sales Flat MT
Earnings Flash (PRGO) PERRIGO COMPANY Reports Q4 Revenue $1.16B, vs. Street Est of $1.17B MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q4 EPS $0.86, vs. Street Est of $0.83 MT
Perrigo Company plc Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023 CI
Perrigo Company plc Reports Earnings Guidance for the Fiscal Year 2024 CI
Perrigo Company plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Perrigo Raises Quarterly Dividend to $0.276 a Share From $0.273, Payable March 26 to Shareholders of Record March 8 MT
Perrigo Company plc Increases its Quarterly Dividend, Payable on March 26, 2024 CI
Transcript : Perrigo Company plc Presents at 2023 Morgan Stanley Global Consumer and Retail Conference, Dec-06-2023 01:30 PM
Chart Perrigo Company plc
More charts
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.32 USD
Average target price
39.75 USD
Spread / Average Target
+31.10%
Consensus
  1. Stock Market
  2. Equities
  3. PRGO Stock
  4. News Perrigo Company plc
  5. Perrigo Co Insider Bought Shares Worth $252,168, According to a Recent SEC Filing